In addition, we investigated co-staining of dormancy markers EphA5, IGFBP5 and H2BK with selected neural and embryonic stem cell markers that we and others have previously shown to be relevant in gliomas [13]. The gene discussed is H2BC12; the disease is central nervous system cancer.